While being hospitalized at IOCN, the attending physician can present you the opportunity to participate at a clinical trial, because this raises a medical interest in the context of your attendance.
What is a clinical trial in oncology?
The clinical trial has the aim of evaluating new cancer treatments, determining their efficiency, and the tolerance of the organism, so that in the future, a large number of patients can benefit from them.
These trials can be made at the initiative of the pharmaceutical industry, or at the initiative of the Institute. The clinical trials are validated by strict scientific protocols, and they respect the ethical principles and the interests of the persons involved.
If I decide to participate at a clinical trial, can I change my mind afterwards?
The participation at a clinical trial is a voluntary and optional action. In order to be able to take a decision, the attending physician will give you all the details you need in written form: the objectives, the risks, the inconveniences, the modalities the trial is applied.
At the appointment with the physician, don’t hesitate to ask all the questions you have. You will have time to think at your decision, after you read all the medical information and the conditions of the consent.
The investigations and the treatments relied to the clinical trials cannot be made and applied without the written consent of the patient. You have the right to refuse the participation at a clinical trial, and this will not affect your treatment inside the Institute. If you accept to participate, you will have to sign the informed consent documents, but you always retain the right to leave the study at any time for any reason.